From: Soluble ST2 is a sensitive clinical marker of ulcerative colitis evolution
Number | |
---|---|
Number of patients | 26 |
Number of patients dropped out | 2 |
Female/male | 16/10 |
Median [range] age at entry | 34.5 [30.0–52.5] |
Duration of UC, years (median, range) | 4.0 [1.3–11.8] |
Age at diagnosis, years (median, range) | 32.0 [22.5–44.0] |
Location | |
Proctitis | 6 |
Left-sided | 5 |
Extensive | 15 |
Clinical disease activity | |
Mild/ Moderate/ Severe | 0/14/12 |
Endoscopic severity | |
Moderate (score 2) / Severe (score 3) | 22/4 |
Medication used | |
No medication | 3 |
5-ASA | 11 |
Corticosteroids and 5-ASA | 3 |
Corticosteroids, 5-asa and azathioprine | 5 |
Corticosteroids and azathioprine | 1 |
5-ASA and azathioprine | 3 |
Response to therapy | 21 |
Reactivation (after/before 6 months) | 6 (1/5) |
Rescued by anti-TNF-α | 6 |